InsiderClue
Stocks · Health care · Pharmaceutical Preparations

BIOVIE INC.

BIVI Clue Score51
United States Fiscal year ends June CIK 0001580149
$1.39 +8.59% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.39 −74.86% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2017Operating income−1.6Net income−1.3Fiscal year 2018Operating income−2.4Net income−2.4Fiscal year 2019Operating income−2.5Net income−2.4EPS, diluted−0.98Fiscal year 2020Operating income−2.7Net income−16.7EPS, diluted−6.85Fiscal year 2021Operating income−138.1Net income−130.2EPS, diluted−14.82Fiscal year 2022Operating income−27.3Net income−26.1EPS, diluted−1.06Fiscal year 2023Operating income−45.1Net income−50.3EPS, diluted−15.47Fiscal year 2024Operating income−32.2Net income−32.1EPS, diluted−73.05Fiscal year 2025Operating income−18.1Net income−17.5EPS, diluted−12.12Fiscal year 2026Operating income−22.7Net income−22.1EPS, diluted−3.05
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating income −1.6 −2.4 −2.5 −2.7 −138.1 −27.3 −45.1 −32.2 −18.1 −22.7
Net income −1.3 −2.4 −2.4 −16.7 −130.2 −26.1 −50.3 −32.1 −17.5 −22.1
Growth
EPS, diluted n/a n/a −0.98 −6.85 −14.82 −1.06 −15.47 −73.05 −12.12 −3.05

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2017Operating cash flow−0.6Fiscal year 2018Operating cash flow−0.6Fiscal year 2019Operating cash flow−2.5Fiscal year 2020Operating cash flow−1.6Fiscal year 2021Operating cash flow−10.5Fiscal year 2022Operating cash flow−19.0Fiscal year 2023Operating cash flow−40.3Fiscal year 2024Operating cash flow−27.9Fiscal year 2025Operating cash flow−19.0Fiscal year 2026Operating cash flow−19.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −0.6 −0.6 −2.5 −1.6 −10.5 −19.0 −40.3 −27.9 −19.0 −19.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Shareholders’ equity1.2Fiscal year 2018Shareholders’ equity0.1Fiscal year 2019Shareholders’ equity2.1Fiscal year 2020Cash0.0Total debt0.1Net cash (debt)−0.0Shareholders’ equity−21.5Fiscal year 2021Cash4.5Shareholders’ equity5.1Fiscal year 2022Cash18.6Shareholders’ equity3.7Fiscal year 2023Cash19.5Shareholders’ equity15.3Fiscal year 2024Cash23.8Shareholders’ equity15.5Fiscal year 2025Cash17.5Shareholders’ equity19.0Fiscal year 2026Cash9.0Shareholders’ equity10.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash n/a n/a n/a 0.0 4.5 18.6 19.5 23.8 17.5 9.0
Total debt n/a n/a n/a 0.1 n/a n/a n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a −0.0 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 1.2 0.1 2.1 −21.5 5.1 3.7 15.3 15.5 19.0 10.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025 FY2026 30 Jun 2026
Returns
−115.0% −2,189.0% −114.7% n/a −2,579.0% −710.6% −327.6% −207.1% −92.3% −214.9%
−56.3% −111.9% −94.9% −800.3% −2,154.1% −129.7% −143.2% −127.4% −81.4% −154.9%
Balance and payout
51.0% 94.9% 17.2% 1,131.6% 16.5% 81.7% 56.3% 38.5% 11.8% 27.9%